drugset / Trial / NCT03432195

A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations

NCT03432195

Phase 1 Completed 66 enrolled Corium, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A Phase 1, Crossover Study to Evaluate the Pharmacokinetics of Corplex™ Donepezil 10 mg Transdermal Delivery System Applied to Different Body Locations

Timeline

Start
2018-01-31
Primary completion
2018-06-28
Completion
2018-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 10 mg Other

Indications